Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Waldmann

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
Molecular and Cellular Endocrinology|February 20, 2017
JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomicsThomas A Waldmann
The Journal of Investigative Dermatology. Symposium Proceedings|December 12, 2013
The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disordersThomas A Waldmann
Human Vaccines & Immunotherapeutics|November 28, 2018
Making discoveries in immunologyThomas A Waldmann
Journal of Clinical Immunology|May 10, 2002
The IL-2/IL-15 receptor systems: targets for immunotherapyThomas A Waldmann
Nature Medicine|March 4, 2003
Immunotherapy: past, present and futureThomas A Waldmann
Immunity|October 18, 2003
A novel means of favorably tipping the balance between cytopathic and regulatory T cellsThomas A Waldmann
Expert Opinion on Drug Delivery|May 3, 2020
Bench-to-bedside translation of interleukin-15 for immunotherapy: principles and challengesChalet Tan, Thomas A Waldmann
Cancer Research|February 28, 2002
Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemiaChalet Tan, Thomas A Waldmann
Annual Review of Immunology|February 10, 2017
Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for ImmunotherapyThomas A Waldmann, Jing Chen
Blood|January 5, 2013
GVL for ATL?Nirali N Shah, Thomas A Waldmann
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
Molecular and Cellular Endocrinology|February 20, 2017
JAK/STAT pathway directed therapy of T-cell leukemia/lymphoma: Inspired by functional and structural genomicsThomas A Waldmann
The Journal of Investigative Dermatology. Symposium Proceedings|December 12, 2013
The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disordersThomas A Waldmann
Human Vaccines & Immunotherapeutics|November 28, 2018
Making discoveries in immunologyThomas A Waldmann
Journal of Clinical Immunology|May 10, 2002
The IL-2/IL-15 receptor systems: targets for immunotherapyThomas A Waldmann
Nature Medicine|March 4, 2003
Immunotherapy: past, present and futureThomas A Waldmann
Immunity|October 18, 2003
A novel means of favorably tipping the balance between cytopathic and regulatory T cellsThomas A Waldmann
Expert Opinion on Drug Delivery|May 3, 2020
Bench-to-bedside translation of interleukin-15 for immunotherapy: principles and challengesChalet Tan, Thomas A Waldmann
Cancer Research|February 28, 2002
Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemiaChalet Tan, Thomas A Waldmann
Annual Review of Immunology|February 10, 2017
Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for ImmunotherapyThomas A Waldmann, Jing Chen
Blood|January 5, 2013
GVL for ATL?Nirali N Shah, Thomas A Waldmann
Pageof 22